Two Sigma Securities’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,280
| Closed | -$40K | – | 1528 |
|
|
2019
Q4 | $40K | Buy |
+12,280
| New | +$40K | ﹤0.01% | 701 |
|
|
2019
Q3 | – | Sell |
-23,873
| Closed | -$75K | – | 1504 |
|
|
2019
Q2 | $75K | Buy |
23,873
+11,488
| +93% | +$36.1K | ﹤0.01% | 688 |
|
|
2019
Q1 | $46K | Sell |
12,385
-8,640
| -41% | -$32.1K | ﹤0.01% | 666 |
|
|
2018
Q4 | $61K | Buy |
+21,025
| New | +$61K | ﹤0.01% | 968 |
|
|
2018
Q3 | – | Sell |
-12,985
| Closed | -$30K | – | 1793 |
|
|
2018
Q2 | $30K | Sell |
12,985
-9,213
| -42% | -$21.3K | ﹤0.01% | 960 |
|
|
2018
Q1 | $65K | Sell |
22,198
-3,829
| -15% | -$11.2K | ﹤0.01% | 975 |
|
|
2017
Q4 | $71K | Buy |
+26,027
| New | +$71K | ﹤0.01% | 791 |
|
|
2017
Q3 | – | Sell |
-16,325
| Closed | -$40K | – | 1363 |
|
|
2017
Q2 | $40K | Sell |
16,325
-49,092
| -75% | -$120K | 0.01% | 732 |
|
|
2017
Q1 | $148K | Buy |
+65,417
| New | +$148K | 0.03% | 712 |
|
|
2016
Q3 | – | Sell |
-36,084
| Closed | -$113K | – | 888 |
|
|
2016
Q2 | $113K | Buy |
+36,084
| New | +$113K | 0.06% | 311 |
|